Scholars International Conference on Pharmaceutics and Drug Delivery Research

December 2-3, 2019 | Spain

Scholars International Conference on Pharmaceutics and Drug Delivery Research is organized by Scholars International Limited and will be held from Dec 02 - 03, 2019 at Rafael hoteles Forum Alcala, Madrid, Spain.

Spotlight

Control of infection from methicillin resistant Staphylococcus aureus (MRSA) has been a healthcare focus for more than 50 years. One of the reasons that active surveillance testing (AST) for MRSA is expected to be effective is that the greatest risk factor for developing clinical disease is to first become colonized in the nares with MRSA. Critically, persons who are either colonized or infected with MRSA are equally likely to have their skin and surrounding environment contaminated with this organism. Therefore, strategies to limit transmission that consider both colonized and infected persons are most likely to be successful at reducing disease. For healthcare organizations that do not have MRSA well controlled, the recent SHEA compendium recommends AST as one method to identify carriers and reduce spread to new patients. NorthShore University HealthSystem began an AST program for MRSA control on August 1, 2005 and realized a 70% reduction in clinical MRSA disease. Careful monitoring of patient benefit and cost reduction associated with lowered healthcare associated infection justifies the program to hospital administration. In 10 years the MRSA control program led to a net healthcare benefit of $20 million in reduced cost, with more than 1,000 infections avoided and 180 prevented deaths.


OTHER PAST CONFERENCES

Health Innovation- Virtual Event

December 8, 2021 | Canada

The impact of COVID-19, along with the advent of new technologies, is transforming the way health care is being delivered in Canada. This rapid growth and the adoption of new delivery models, such as digital health, has created new operational challenges, and required a rethinking and new approach to service delivery. The end goal being a system that is more predictive, preventative, personalized and participatory going forward. Public Sector Network’sHealth Innovationvirtual event will bring together top health professionals who are piloting the way with new and progressive digital healthcare initiatives. With digital innovation now empowering patients to play a more active role in their own care, the need to modernize the health care during this time of transformation is critical for a more responsive and positive citizen experience.

Data & Analytics in Healthcare

December 2, 2021 | Canada

The ability to leverage data, analytics and big data in the healthcare space is revolutionary. The opportunity to quickly analyse accurate data enables decisionmakers to make choices regarding treatment, predict the path of large-scale health events, and plan long-term. Join us to help your organisation extract the best insights from data to enhance patient outcomes and workflows, while maintaining transparency and responsibility, at thecomplimentaryData & Analytics for Healthcarevirtual event.

HFMA Annual Conference 2021

November 8-10, 2021 | USA

HFMA’s Annual Conference is the industry’s premier healthcare finance conference, attracting more than 3,800 professionals each year. Attendees look forward to interacting with peers, connecting with industry leaders and connecting with business partners on the show floor to gain insights on complex issues and solutions to solve problems.

Clean Med Europe 2021

November 29-December 3, 2021 | Belgium

CleanMed Europe is the only place where healthcare leaders come together from across Europe and beyond to share ideas, innovations, challenges, and solutions for sustainability in European healthcare. The online conference showcases cutting-edge practices in sustainable healthcare and is the ideal venue for healthcare innovators to network and share ideas, finding new ways to drive change within their organisations and communities.

Spotlight

Control of infection from methicillin resistant Staphylococcus aureus (MRSA) has been a healthcare focus for more than 50 years. One of the reasons that active surveillance testing (AST) for MRSA is expected to be effective is that the greatest risk factor for developing clinical disease is to first become colonized in the nares with MRSA. Critically, persons who are either colonized or infected with MRSA are equally likely to have their skin and surrounding environment contaminated with this organism. Therefore, strategies to limit transmission that consider both colonized and infected persons are most likely to be successful at reducing disease. For healthcare organizations that do not have MRSA well controlled, the recent SHEA compendium recommends AST as one method to identify carriers and reduce spread to new patients. NorthShore University HealthSystem began an AST program for MRSA control on August 1, 2005 and realized a 70% reduction in clinical MRSA disease. Careful monitoring of patient benefit and cost reduction associated with lowered healthcare associated infection justifies the program to hospital administration. In 10 years the MRSA control program led to a net healthcare benefit of $20 million in reduced cost, with more than 1,000 infections avoided and 180 prevented deaths.

resources